World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
117
Citations
63429
World Ranking
418
National Ranking
248

Medicine

D-Index
117
Citations
63468
World Ranking
4142
National Ranking
2269

Overview

Martin R. Farlow is affiliated with Indiana University in the United States and has made notable contributions within the field of Medicine, focusing primarily on areas such as Physiology, Psychiatry and Mental Health, Molecular Biology, Cognitive Neuroscience, and Neurology.

Their research covers a range of topics, including:

  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Functional Brain Connectivity Studies
  • Bioinformatics and Genomic Networks
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Advanced Neuroimaging Techniques and Applications
  • Health, Environment, Cognitive Aging

Recent publications by Martin R. Farlow illustrate a focus on Alzheimer's disease and related neurological conditions. Selected papers include:

  • "A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease" (2020), published in Nature Medicine
  • "Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study" (2020), published in Nature Communications
  • "Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy" (2021), published in Nature
  • "A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease" (2021), published in Nature Medicine
  • "Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid" (2022), published in Nature

Frequent co-authors collaborating with Martin R. Farlow include:

  • Randall J. Bateman
  • Jasmeer P. Chhatwal
  • Carlos Cruchaga
  • John C. Morris
  • Eric McDade

Martin R. Farlow's research has been published across multiple prominent scientific venues, with frequent appearances in:

  • Alzheimer's & Dementia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Nature Medicine
  • JAMA Neurology

Best Publications

  • Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

    Unknown

  • Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

    Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang

  • A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

    S. L. Rogers;M. R. Farlow;R. S. Doody;R. Mohs

  • Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

    Pierre N. Tariot;Martin R. Farlow;George T. Grossberg;Stephen M. Graham

  • Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

    RS Rachelle S. Doody;RG Ronald G. Rg Thomas;Martin Farlow;Takeshi Iwatsubo

  • The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.

    Harald Hampel;M.-Marsel Mesulam;A Claudio Cuello;Martin R Farlow

  • Mutation in the tau gene in familial multiple system tauopathy with presenile dementia

    Maria Grazia Spillantini;Jill R. Murrell;Michel Goedert;Martin R. Farlow

  • A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.

    Jill Murrell;Martin Farlow;Bernardino Ghetti;Merrill D. Benson

  • A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

    Rachelle S. Doody;Rema Raman;Martin Farlow;Takeshi Iwatsubo

  • A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease

    Margaret J. Knapp;David S. Knopman;Paul R. Solomon;William W. Pendlebury

  • Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.

    Piero Parchi;Rudolph Castellani;Sabina Capellari;Bernardino Ghetti

  • Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial

    Paul S. Aisen;Kimberly A. Schafer;Michael Grundman;Eric Pfeiffer

  • Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

    Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease

    Oliver Preische;Oliver Preische;Stephanie A. Schultz;Anja Apel;Anja Apel;Jens Kuhle

  • A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.

    Martin Farlow;Stephen I. Gracon;Linda A. Hershey;Karen W. Lewis

  • Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.

    Judes Poirier;Marie Claude Delisle;Rémi Quirion;Isabelle Aubert

  • A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.

    Nicolas R Barthélemy;Yan Li;Nelly Joseph-Mathurin;Brian A Gordon

  • Cerebrospinal Fluid Tau and β-Amyloid: How Well Do These Biomarkers Reflect Autopsy-Confirmed Dementia Diagnoses?

    Christopher M. Clark;Sharon Xie;Jesse Chittams;Douglas Ewbank

  • Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments

    Maria Grazia Spillantini;Michel Goedert;R. Anthony Crowther;Jill R. Murrell

  • A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.

    Martin Farlow;Ravi Anand;John Messina;Richard Hartman

Frequent Co-Authors

Bernardino Ghetti
Bernardino Ghetti Indiana University
Andrew J. Saykin
Andrew J. Saykin Indiana University
Shannon L. Risacher
Shannon L. Risacher Indiana University
John C. Morris
John C. Morris Washington University in St. Louis
Liana G. Apostolova
Liana G. Apostolova Indiana University
Stephen Salloway
Stephen Salloway Brown University
Frederick W. Unverzagt
Frederick W. Unverzagt Indiana University
Randall J. Bateman
Randall J. Bateman Washington University in St. Louis
Tatiana Foroud
Tatiana Foroud Indiana University
Paul S. Aisen
Paul S. Aisen University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Neuroscience can open doors to many rewarding careers. For those who want to integrate psychology practice, pursuing online psyd programs accredited by apa is a pathway to becoming a licensed psychologist. These APA-accredited programs ensure rigorous training, even in an online format.

If you are interested in therapy and family dynamics, the best online mft programs offer a direct route to becoming a Marriage and Family Therapist. Many of these programs are designed for flexibility, enabling you to balance your studies with personal commitments.

Not everyone is ready for a doctorate. An online bachelor's degree in neuroscience or a related field can help you get started quickly, sometimes in less time than traditional programs. This is a practical path for those eager to enter the field or advance to graduate studies.

Thinking about long-term earning potential? Review the high paying degrees in health, science, and technology. Understanding the financial outcomes can help align your education with your career and lifestyle goals.

Best Scientists Citing Martin R. Farlow

Trending Scientists